I 

115TH CONGRESS 

1ST SESSION H. R. 1492 

To amend the Controlled Substances Act to direct the Attorney General 

to register practitioners to transport controlled substances to States 

in which the practitioner is not registered under the Act for the purpose 

of administering the substances (under applicable State law) at locations 

other than principal places of business or professional practice. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 10, 2017 

Mr. SESSIONS introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on 

the Judiciary, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Controlled Substances Act to direct the Attorney General to register practitioners to transport controlled substances to States in which the practitioner 

is not registered under the Act for the purpose of administering the substances (under applicable State law) at 

locations other than principal places of business or professional practice. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


SSpencer on DSK4SPTVN1PROD with BILLS
2 

•HR 1492 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Medical Controlled 

3 Substances Transportation Act of 2017’’. 

4 SEC. 2. REGISTRATION FOR TRANSPORT OF CONTROLLED 

5 SUBSTANCES TO STATES IN WHICH THE 

6 PRACTITIONER IS NOT REGISTERED UNDER 

7 THE CONTROLLED SUBSTANCES ACT FOR 

8 THE PURPOSE OF ADMINISTERING THE SUB9 STANCES AT LOCATIONS OTHER THAN PRIN10 CIPAL PLACES OF BUSINESS OR PROFES11 SIONAL PRACTICE. 

12 Section 303 of the Controlled Substances Act (21 

13 U.S.C. 823) is amended by adding at the end the fol14 lowing: 

15 ‘‘(k) REGISTRATION FOR TRANSPORT OF CON16 TROLLED SUBSTANCES TO STATES IN WHICH THE PRAC17 TITIONER IS NOT REGISTERED FOR THE PURPOSE OF

18 ADMINISTERING THE SUBSTANCES AT LOCATIONS OTHER

19 THAN PRINCIPAL PLACES OF BUSINESS OR PROFES20 SIONAL PRACTICE.— 

21 ‘‘(1) IN GENERAL.—Upon application by a 

22 practitioner (other than a pharmacy) who is reg23 istered under subsection (f), the Attorney General 

24 shall issue a separate registration to the practitioner 

25 authorizing the practitioner— 


SSpencer on DSK4SPTVN1PROD with BILLS
3 

•HR 1492 IH

1 ‘‘(A) to transport one or more controlled 

2 substances in schedule II, III, IV, or V from 

3 the practitioner’s registered location in a State 

4 to one or more States in which the practitioner 

5 is not registered under subsection (f) for the 

6 purpose of the practitioner administering the 

7 substances at locations other than a principal 

8 place of business or professional practice; and 

9 ‘‘(B) to so administer the substances. 

10 ‘‘(2) REQUIREMENTS.—For a practitioner to be 

11 authorized to transport and administer controlled 

12 substances pursuant to a registration issued under 

13 paragraph (1), all of the following conditions must 

14 be satisfied: 

15 ‘‘(A) The practitioner must be licensed, 

16 registered, or otherwise permitted by the State 

17 in which the controlled substances are adminis18 tered to carry out such activity at the location 

19 where it occurs. 

20 ‘‘(B) The practitioner must— 

21 ‘‘(i) limit the time of transport and 

22 administering of any controlled substance 

23 pursuant to such registration to not more 

24 than 72 consecutive hours; and 


SSpencer on DSK4SPTVN1PROD with BILLS
4 

•HR 1492 IH

1 ‘‘(ii) by the conclusion of such 72 

2 hours, return any such controlled sub3 stance so transported but not administered 

4 to the registered location from which such 

5 substance was obtained. 

6 ‘‘(C)(i) The practitioner must maintain 

7 records of the transporting and administering 

8 of any controlled substance pursuant to this 

9 subsection. 

10 ‘‘(ii) Such records shall be maintained, in 

11 accordance with the requirements of section 

12 307(b), at the practitioner’s registered location 

13 from which the controlled substances were ob14 tained and shall include— 

15 ‘‘(I) the location where the controlled 

16 substance was administered; and 

17 ‘‘(II) such other information as may 

18 be required by regulation of the Attorney 

19 General with respect to records for dis20 pensers of controlled substances. 

21 ‘‘(iii) Notwithstanding clause (ii), the ex22 ception in subsection 307(c)(1)(B) shall not 

23 apply to records required by this subparagraph. 

24 ‘‘(3) GROUNDS FOR DENIAL OR REVOCATION.— 

25 The Attorney General may deny an application for 


SSpencer on DSK4SPTVN1PROD with BILLS
5 

•HR 1492 IH

1 registration under this subsection, or a renewal 

2 thereof, or revoke such registration, based on the 

3 criteria listed in section 304(a), except that the ap4 plicant shall not be required, as a condition of ini5 tially obtaining such registration, to present proof of 

6 State authorization to administer controlled sub7 stances. 

8 ‘‘(4) AUTOMATIC TERMINATION.—A registra9 tion issued under this subsection shall automatically 

10 terminate if the practitioner no longer has an active 

11 registration under subsection (f) due to revocation, 

12 suspension, surrender, or other termination. 

13 ‘‘(5) DEFINITION.—In this subsection, the term 

14 ‘registered location’ means, with respect to each reg15 istration issued to a practitioner under subsection 

16 (f), the address that appears on the certificate of 

17 registration.’’. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS